newsroom

<< back to overview

Join the second HD spotlight webinar with Xia Tao

Created on 03/05/2022 09:00

In this webinar, in addition to addressing the fundamental elements of membrane characteristics involved in uremic toxin removal, a new evidence-linked uraemic toxin elimination (ELUTE) approach will be introduced.

Two weeks ago the new HD spotlight webinar series, chaired by Prof. Dr. Peter Stenvinkel, Karolinska Institutet Stockholm, Sweden, kicked off. Join the next event on May 10, 2022/ 4 - 5pm CEST!
 
The upcoming webinar, delivered by Xia Tao, MD, PhD, Renal Research Institute, USA, focuses on: the membrane perspective of uremic toxins: which ones should, or can, be removed and how much? The webinar will be followed by a live discussion and will be recorded to enable on-demand access afterwards.

 

what HD spotlight is about
HD spotlight is for nephrology professionals who appreciate timely, insightful content delivered by eight international speakers to lead curated webinar sessions spanning the spectrum of current dialysis membrane topics. Check the list of eight current dialysis topics below

 

all eight webinars are chaired by Prof. Peter Stenvinkel, MD, PhD, Karolinska Institutet, Sweden.

 

part 01: perceiving the pivotal attributes of hemodialysis therapy

 

May 10, 2022/ 4 – 5 pm CEST
02. The membrane perspective of uremic toxins: 
which ones should, or can, be removed and how much?
How to choose a dialyzer? Which molecules to target? 
Are large middle molecules really bad?&nbsp
Can we risk albumin removal?
speaker: Xia Tao, MD, PhD, Renal Research Institute, USA

 

June 7, 2022/ 5 – 6 pm CEST
03. Choices in hemodialysis: variants, personalized 
therapy & application of evidence-based medicine
How to choose a therapy? What are the therapy options?&nbsp
What is EBM?
speaker: Stefano Stuard, MD, PhD, Fresenius Medical Care, Italy

 

June 14, 2022/ 5 – 6 pm CEST
04. Flummoxed by flux: 
the indeterminate principles of hemodialysis
What is flux?
speaker: Prof. Madhukar Misra, MD, University of Missouri, USA

 

part 02: mitigating the ramifications of hemodialysis

 

September 13, 2022/ 5 – 6 pm CEST
05. Hemoincompatibility in hemodialysis: 
alleviating inflammation and anticoagulation
What is hemocompatibility? What are adverse events? 
What is complement activation?
How to manage hemoincompatibility?
speaker: Prof. Alberto Ortiz Arduan, MD, PhD, University Autonoma de Madrid, Spain

 

October 4, 2022/ 5 – 6 pm CEST
06. Multitargeted interventions to reduce 
dialysis-induced systemic stress
How to manage systemic stress? What is systemic stress?
speaker: Prof. Bernard Canaud, MD, Montpellier University and Fresenius Medical Care, France

 

November 15, 2022/ 5 – 6 pm CET
07. Clinical relevance of abstruse 
transport phenomena in hemodialysis
How to select a membrane. Risks and benefits of larger pore size.
speaker: Mooppil Nandakumar, MBBS, Fresenius Medical Care, Singapore

 

December 6, 2022/ 5 – 6 pm CET
08. Informed decision-making in delivery of dialysis: 
combining clinical outcomes with sustainability
What are the factors to consider when choosing a more expensive therapy? 
Guidance on points to tackle from HEMA perspective.
5P approach
speaker: Christian Apel, Fresenius Medical Care, Germany

 

recent webinars

 

April 26, 2022/ 5 – 6 pm CEST
01. The scientific and technological determinants 
of hemodialysis membranes
What goes on inside a dialyzer?
speaker: Fatih Kircelli, MD, Fresenius Medical Care, Germany

<< back to overview